Chemomab Therapeutics (CMMB) Tops Q1 EPS by 3c

May 9, 2024 7:43 AM EDT

Chemomab Therapeutics (NASDAQ: CMMB) reported Q1 EPS of $0.01, $0.03 better than the analyst estimate of ($0.02).

For earnings history and earnings-related data on Chemomab Therapeutics (CMMB) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings